21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Random plasma glucose in early pregnancy is a better predictor of gestational diabetes diagnosis than maternal obesity

      research-article
      , ,
      Diabetologia
      Springer Berlin Heidelberg

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims/hypothesis

          Asymptomatic pregnant women are screened for gestational diabetes (GDM) at 24–28 weeks’ gestation. Recent guidelines also recommend screening early in gestation to identify undiagnosed pre-existing overt diabetes. We assessed the performance of random plasma glucose (RPG) testing at antenatal booking in predicting GDM diagnosis later in pregnancy.

          Methods

          Data from 25,543 consecutive singleton pregnancies at the Rosie Hospital in Cambridge (UK) were obtained from hospital electronic records as a service evaluation. All women were invited for an antenatal RPG (12–16 weeks) and a 50 g glucose challenge test (GCT; 24–28 weeks) with a 75 g OGTT if GCT >7.7 mmol/l (139 mg/dl).

          Results

          At booking, 17,736 women had an RPG that was able to predict GDM (receiver operating characteristic AUC 0.8) according to various diagnostic criteria in common use. A cut-off point of ≥7.5 mmol/l (135 mg/dl) gave a sensitivity of 0.70 and a specificity of 0.90 for GDM diagnosis. Theoretically, using this screening policy, 13.2% of women would have been categorised at high risk (26.3% had GDM) and 86.8% of women at low risk (1.7% had GDM). RPG performed better than maternal age (AUC 0.60) or BMI (AUC 0.65) at predicting GDM diagnosis.

          Conclusions/interpretation

          RPG at booking has reasonable performance as a screening test and is better than maternal age or BMI for identifying women at high risk of GDM. RPG cannot replace OGTT for diagnosis but it may be useful to exclude women who do not need further investigation for GDM and to identify women who could be prioritised for early diagnosis or lifestyle interventions.

          Electronic supplementary material

          The online version of this article (doi:10.1007/s00125-015-3811-5) contains peer-reviewed but unedited supplementary material, which is available to authorised users.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: not found
          • Article: not found

          International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy: Response to Weinert

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Practice Bulletin No. 137: Gestational diabetes mellitus.

              (2013)
              Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. Debate continues to surround both the diagnosis and treatment of GDM despite several recent large-scale studies addressing these issues. The purpose of this document is to 1) provide a brief overview of the understanding of GDM, 2) provide management guidelines that have been validated by appropriately conducted clinical research, and 3) identify gaps in current knowledge toward which future research can be directed.
                Bookmark

                Author and article information

                Contributors
                clm70@cam.ac.uk
                Journal
                Diabetologia
                Diabetologia
                Diabetologia
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0012-186X
                1432-0428
                20 November 2015
                20 November 2015
                2016
                : 59
                : 445-452
                Affiliations
                [ ]The Wellcome Trust–MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Box 289, Hills Road, Cambridge, CB2 0QQ UK
                [ ]Wolfson Diabetes and Endocrinology Clinic, Cambridge University Hospitals, Addenbrooke’s Hospital, Cambridge, UK
                [ ]Department of Clinical Biochemistry, Cambridge University Hospitals, Addenbrooke’s Hospital, Cambridge, UK
                [ ]Department of Medicine, University of East Anglia, Norwich Medical School, Norwich, UK
                [ ]School of Medicine, University of Western Sydney, Campbelltown, NSW Australia
                Article
                3811
                10.1007/s00125-015-3811-5
                4742503
                26589686
                894f82d2-b23a-4790-8fec-4e7066f57fa1
                © The Author(s) 2015

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 18 August 2015
                : 23 October 2015
                Categories
                Article
                Custom metadata
                © Springer-Verlag Berlin Heidelberg 2016

                Endocrinology & Diabetes
                Endocrinology & Diabetes

                Comments

                Comment on this article